What is Hannah Joseph IPO GMP Today?
The Latest GMP of Hannah Joseph IPO is ₹0.
Hannah Joseph IPO gmp
| DATE | GMP (GREY MARKET PREMIUM) | EXPECTED LISTING GAINS |
|---|---|---|
| 27-Jan-2026 | – | – |
| 26-Jan-2026 | – | – |
| 25-Jan-2026 | – | – |
| 24-Jan-2026 | – | – |
| 23-Jan-2026 | – | – |
| 22-Jan-2026 | – | – |
| 21-Jan-2026 | – | – |
IPO Grey Market Premium (GMP)
The grey market premium (GMP) represents the informal trading price in grey market of an IPO before it officially lists on the stock exchange. The GMP can provide an early snapshot of investor sentiment and the expected demand for shares once they are listed. A higher GMP generally suggests positive market expectations, while a lower or negative GMP may indicate cautious sentiment.
It is important to remember that GMP values are purely indicative and can change rapidly due to short-term market factors, speculative trading, or investor perception. They do not guarantee how the IPO will perform on the listing day.
Investors should not base their investment decision solely on GMP. Instead, a careful analysis of the company’s business model, financial health, industry position, and growth potential should guide the decision to participate in the IPO. Using GMP as one of many reference points can help, but relying on it alone carries significant risk.
Company Brief – Hannah Joseph Hospital Ltd
Hannah Joseph Hospital Limited, based in Madurai, Tamil Nadu, is a multi‑specialty tertiary care hospital with a strong focus on neurosciences and trauma care. The hospital has expanded into oncology, cardiology, and advanced surgical services, supported by modern infrastructure and skilled medical professionals.
The IPO proceeds will fund the establishment of a Radiation Oncology Centre, enhancing its clinical offerings. Financially, Hannah Joseph reported ₹77.90 crore revenue in FY2025 compared to ₹63.63 crore in FY2024, with profit after tax of ₹7.21 crore in FY2025 versus ₹14.07 crore in FY2024. Despite margin fluctuations, the hospital demonstrates strong patient inflows and sustainable growth potential.
IPO Dates
| Event | Date |
| Issue Opening Date | 22 Jan 2026 |
| Issue Closing Date | 27 Jan 2026 |
| Allotment Date* | 28 Jan 2026 |
| Refunds Initiation* | 29 Jan 2026 |
| Credit of Shares to Demat* | 29 Jan 2026 |
| IPO Listing Date* | 30 Jan 2026 |
*Tentative
IPO Details
| Detail | Value |
| Issue Price | ₹67–₹70 per equity share |
| Market Lot | 1,500 shares |
| Minimum Investment (Retail) | ₹1,05,000 |
| IPO Listing At | BSE SME |
| Issue Type | Book Build Issue |
| Total Issue Size | ₹42 crore |
| Face Value | ₹10 per equity share |
| Promoter Holding Pre IPO | 100% |
| Promoter Holding Post IPO | ~70% |
Reservation
| Investor Category | Shares Offered |
| QIB | 28,46,000 shares (~47%) |
| Retail | 19,96,000 shares (~33%) |
| NII (HNI) | 8,58,000 shares (~14%) |
| Market Maker | 3,00,000 shares (~5%) |
| Total Shares Offered | 60,00,000 |